Clinical Trial Update: Nitroglycerin as Spasmolytic Regimen for RAS Prevention in Radial Center [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating nitroglycerin as a spasmolytic regimen to prevent radial artery spasm after radial artery injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radial Artery Injury

Drugs mentioned

• NITROGLYCERIN (Nitroglycerin)

Snippet

Sponsor: Hermina Heart Center Kemayoran | Conditions: Radial Artery Injury | Phase 4 | Status: UNKNOWN